Direct Oral Anticoagulants: Probability of Recurrent Venous Thromboembolism and Bleeding Risk in an Obese Population
CONCLUSIONS: These findings support the conclusion that DOACs are an appropriate and effective drug class for the management of VTE in patients with obesity.PMID:37994550 | DOI:10.1177/10600280231212186
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Courtney S Pilkerton Megan Adelman Emily Crocetti Jun Xiang Victoria Strick Charles D Ponte Shaylee Peckens Benjamin P Jackson Kylen Whipp Amie M Ashcraft Source Type: research
More News: Bleeding | Coumadin | Drugs & Pharmacology | Eating Disorders & Weight Management | Obesity | Study | Thrombosis | USA Health | Vitamin K | Vitamins | Warfarin